XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Feb. 28, 2022
Feb. 28, 2021
Feb. 29, 2020
Cash provided by operating activities:      
Net income $ 223,764,000 $ 253,946,000 $ 152,333,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 35,829,000 37,718,000 37,409,000
Amortization of financing costs 986,000 1,021,000 1,620,000
Non-cash operating lease expense 9,580,000 6,895,000 6,269,000
Provision for credit losses 312,000 2,093,000 529,000
Non-cash share-based compensation 34,618,000 26,418,000 22,929,000
Asset impairment charges 0 8,452,000 41,000,000
Gain on sale of North America Personal Care business (513,000) 0 0
(Gain) loss on the sale or disposal of property and equipment (2,243,000) 193,000 188,000
Deferred income taxes and tax credits (8,871,000) (4,400,000) (5,696,000)
Changes in operating capital, net of effects of acquisition of business:      
Receivables (66,834,000) (38,149,000) (60,562,000)
Inventory (45,913,000) (220,817,000) 45,482,000
Prepaid expenses and other current assets (5,589,000) (2,033,000) 863,000
Other assets and liabilities, net (6,595,000) (6,613,000) 19,488,000
Accounts payable (43,745,000) 175,784,000 7,166,000
Accrued expenses and other current liabilities (3,593,000) 73,010,000 5,296,000
Accrued income taxes 19,630,000 588,000 (3,021,000)
Net cash provided by operating activities 140,823,000 314,106,000 271,293,000
Cash used by investing activities:      
Capital and intangible asset expenditures (78,039,000) (98,668,000) (17,759,000)
Payments to acquire businesses, net of cash acquired (410,880,000) 0 (255,861,000)
Proceeds from sale of North America Personal Care business 44,700,000 0 0
Proceeds from the sale of property and equipment 5,305,000 0 3,000
Net cash used by investing activities (438,914,000) (98,668,000) (273,617,000)
Cash provided (used) by financing activities:      
Proceeds from line of credit 998,200,000 937,400,000 771,300,000
Repayment of line of credit (527,700,000) (928,400,000) (752,500,000)
Repayment of long-term debt (1,900,000) (1,900,000) (1,900,000)
Payment of financing costs 0 (3,796,000) 0
Proceeds from share issuances under share-based compensation plans 5,956,000 5,205,000 8,189,000
Payments for repurchases of common stock (188,204,000) (203,294,000) (10,169,000)
Net cash provided (used) by financing activities 286,352,000 (194,785,000) 14,920,000
Net cash provided (used) by financing activities (11,739,000) 20,653,000 12,596,000
Cash and cash equivalents, beginning balance 45,120,000 24,467,000 11,871,000
Cash and cash equivalents, ending balance 33,381,000 45,120,000 24,467,000
Supplemental cash flow information:      
Interest paid 11,694,000 11,640,000 12,777,000
Income taxes paid, net of refunds 22,831,000 19,692,000 23,279,000
Supplemental non-cash investing activity:      
Capital expenditures included in accounts payable $ 6,858,000 $ 0 $ 0